Oruka Therapeutics, Inc. (ORKA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.38B |
| Enterprise Value | 1.34B |
| P/E Ratio | -43.71 |
| PEG Ratio | -0.81 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.09 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -44.09 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.12 |
| Return On Equity | -0.21 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -83,000 |
| EBITDA | -105.35M |
| Net Income | -105.43M |
| Diluted EPS | -2.31 |
Balance Sheet
| Total Cash | 873.56M |
| Total Cash/Share | 13.89 |
| Total Debt | 2.55M |
| Total Debt/Equity | 0 |
| Current Ratio | 38.51 |
| Book Value Per Share | 17.73 |
Price History
| 52-Week Change | 644.04 |
| 52-Week High | 115.52 |
| 52-Week Low | 14.34 |
| Moving Average 50 Days | 91.43 |
| Moving Average 200 Days | 54.82 |
Statistics
| Average Volume | 1.22M |
| Shares Outstanding | 60.31M |
| % Held by Institutions | 135.07 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | September 03, 2024 |
AD
